miRNA 测序和检测市场预计将从 2019 年的 1.9231 亿美元增至 2027 年的 4.6899 亿美元;预计 2020 年至 2027 年复合年增长率为 11.9%。
miRNA 是一种长度为 20-30 个核苷酸的小非编码 RNA 分子,并且它在基因调控中发挥重要作用。由于它与信使 RNA (mRNA) 部分互补,因此它的主要功能是下调基因表达,这使其成为重要细胞功能的关键控制器。 miRNA 与病毒感染、自身免疫性疾病和癌变等病理过程相关。因此,人们正在进行广泛的研究来鉴定新的 miRNA。 miRNA测序和检测市场的增长主要归因于miRNA应用范围的扩大和基因组学研究资金的增加等因素。然而,与基于 miRNA 的疗法的递送、功效和特异性相关的挑战预计将阻碍市场增长。
miRNA 测序和检测市场的利润丰厚的区域
市场洞察
扩大 MicroRNA 应用范围
miRNA 是一组 20-30 个核苷酸的非编码小 RNA 分子长度。这些分子与目标信使 RNA (mRNA) 结合并导致基因沉默,从而控制基因表达。因此,它们在细胞生理学和发育中发挥着关键作用。 miRNA 调节所有细胞功能,例如细胞增殖、分化和凋亡。它们参与分化过程,在提供组织身份方面发挥着至关重要的作用。因此,miRNA被认为是识别细胞类型的有用标记。
此外,miRNA还与病毒感染、自身免疫性疾病和癌变等病理过程相关。其中一些可以充当癌基因 (oncomiR),而其他一些则充当肿瘤抑制 miRNA。 miRNA 表达的改变与不同类型癌症的发生相关。 miRNA 与下一代测序技术相结合作为一类新型癌症生物标志物的潜力正在被探索。预计它们将在评估癌症的发生、进展、预后、诊断和治疗方面发挥至关重要的作用。此外,几类 miRNA 也已成为由病原体引起的传染病的有前途的生物标志物,包括 HIV、亨德拉病毒、结核病和疟疾。
此外,关于 miRNA 在疾病发展中的作用的发现已经使miRNA 是新型治疗方法的关键靶点。几种针对癌症和肝炎等疾病的 miRNA 靶向疗法已进入临床阶段。例如,Santaris Pharma 开发了一种名为 Miravirsen 的治疗分子,靶向 miR-122,用于治疗丙型肝炎病毒(HCV)感染;该分子正处于 II 期临床试验中。因此,miRNA 应用范围的不断扩大正在推动 miRNA 测序和检测市场的增长。
基于产品的见解
从产品来看,miRNA 测序和检测市场是分为文库制备和耗材。 2019年耗材领域占据了更大的市场份额,而文库制备领域预计在预测期内将在市场上实现更高的复合年增长率。
miRNA测序和分析市场(按产品) 2019年和2027年
基于技术的见解
基于技术,miRNA测序和分析市场分为合成测序、纳米孔测序和离子半导体测序测序。合成测序领域在 2019 年占据了最大的市场份额;然而,纳米孔细分市场预计将在 2020 年至 2027 年实现最高的复合年增长率。
基于最终用户的见解
基于最终用户方面,miRNA 测序和检测市场分为研究机构、学术界和 CRO。研究机构细分市场在 2019 年占据最大市场份额,预计 2020 年至 2027 年复合年增长率最高。
战略见解
合作是这是 miRNA 测序和检测市场参与者为扩大全球客户群而采取的主要策略之一,这也使他们能够在全球范围内维持其品牌名称。
miRNA 测序和检测分析市场 –按产品
- 文库制备
- 耗材
miRNA 测序和检测市场 -按技术划分
- 合成测序
- 纳米孔
- 离子半导体测序
miRNA测序和检测市场&ndash ;按最终用户
- 研究机构
- 学术界
- CRO
miRNA 测序和检测市场 -按地理位置
- 北美洲
- 美国
- 加拿大
- 墨西哥
< li>欧洲 - 法国
- 德国
- 意大利
- 英国
- 西班牙
- 休息欧洲
- 亚太地区 (APAC)
- 中国
- 印度
- 韩国
- 日本
- 澳大利亚
- 亚太地区其他地区
- 中东和非洲 (MEA)
- 南非
- 沙特阿拉伯
- 阿联酋
- 中东和非洲其他地区
- 南部和非洲中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地区
  ;
公司简介
- Illumina Inc.
- Thermo Fisher Scientific Inc.
- Qiagen
- Perkin Elmer Inc.
- Takara Bio Inc.
- 新英格兰生物实验室
- NorgenBiotek Corp
- TriLinkBioTechnologies Inc
- Lexogen GmbH
- 牛津纳米孔技术
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
miRNA is a small non-coding RNA molecule of 20–30-nucleotide length, and it plays an important role in gene regulation. As it is partially complementary to messenger RNA (mRNA), it serves a major function of down-regulating the gene expression, which makes it a key controller of important cellular functions. miRNAs are associated with pathological processes such as viral infections, autoimmune diseases, and carcinogenesis. Thus, extensive research is being conducted to identify new miRNAs.
The growth of the miRNA sequencing and assay market is mainly attributed to the factors such widening range of miRNA applications and rise in funding for genomics research. However, challenges related to delivery, efficacy, and specificity of miRNA-based therapeutics is projected to deter the market growth.
The GMP cytokines market majorly consists of the players such as Illumina, Inc., Thermo Fisher Scientific Inc., Qiagen, Perkin Elmer, Inc., Takara Bio Inc., New England Biolabs, Norgen Biotek Corp, TriLink BioTechnologies Inc, Lexogen GmbH, and Oxford Nanopore Technologies among others.
The List of Companies - MiRNA Sequencing And Assay Market
- Illumina Inc.
- Thermo Fisher Scientific Inc.
- Qiagen
- Perkin Elmer Inc.
- Takara Bio Inc.
- New England Biolabs
- NorgenBiotek Corp
- TriLinkBioTechnologies Inc
- Lexogen GmbH
- Oxford Nanopore Technologies
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Feb 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Feb 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Feb 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Feb 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Feb 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)